E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/6/2005 in the Prospect News PIPE Daily.

New Issue: U.S. Medsys closes $1.5 million private placement of preferreds

By Sheri Kasprzak

Atlanta, April 6 - U.S. Medsys Corp. said it has closed a private placement for $1.5 million.

The company sold 150,000 shares of series A convertible preferred stock at $10.00 each to two individual investors, Joseph Corso Sr. and Joseph Corso Jr.

Each preferred is convertible into 20 common shares. The preferreds do not pay dividends.

The company may force conversion of the preferreds if its stock trades above $3.00 per share for 20 consecutive trading days.

The investors also received warrants for a total of 1 million shares exercisable at $1.50 for three years. The warrants may be redeemed at $0.01 per warrant if the company's stock exceeds $3.00 for 20 consecutive trading days. The expiry will be accelerated to 30 days if this occurs.

Based in Hasbrouck Heights, N.J., U.S. Medsys manufactures and markets medical devices.

Issuer:U.S. Medsys Corp.
Issue:Series A convertible preferred stock
Amount:$1.5 million
Shares:150,000
Price:$10.00
Conversion ratio:Each preferred into 20 common shares
Warrants:For 1 million shares
Warrant expiration:Three years
Warrant strike price:$1.50
Investors:Joseph Corso Sr. and Joseph Corso Jr.
Settlement date:March 31
Stock price:$0.92 at close March 31

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.